Urgent Field Safety Notice for MabTrack level infliximab by HUMAN Gesellschaft für Biochemica und Diagnostica mbH
2022.06.27
Product group In-vitro diagnostics - immunological products
Reference 14506/22
For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.